Evaluation of meningococcal C oligosaccharide conjugate vaccines by size‐exclusion chromatography/multi‐angle laser light scattering
- 23 December 2002
- journal article
- research article
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 36 (3) , 219-226
- https://doi.org/10.1042/ba20020066
Abstract
The mean molecular masses of three different meningococcal C saccharide (MenC)-protein conjugate vaccines and their constituent proteins were estimated using HPLC size-exclusion chromatography (SEC) with multi-angle laser light scattering (MALLS) and refractive-index (RI) detection (SEC/MALLS). Chromatography of two CRM(197) conjugates (MenC-CRM(197)-A and MenC-CRM(197)-B) and one tetanus toxoid (TT) conjugate (MenC-TT) was performed in PBS, pH 7.4, on TSK-Gel (TosoHaas) analytical columns [CRM(197) is a non-catalytic cross-reacting mutant (CRM) of diphtheria toxin]. Analysis of the light-scattering signal measured at 18 angles simultaneously, using the RI signal as a measure of concentration, gave absolute weight-average-molecular-mass (M(w)) values for the CRM(197) conjugates as follows: MenC-CRM(197)-A, approximately 75,000 g x mol(-1) and MenC-CRM(197)-B, approximately 350,000 g x mol(-1), suggesting that MenC-CRM(197)-A is a monomer (one carrier protein per conjugate molecule), while MenC-CRM(197)-B is largely composed of conjugates containing three or four CRM(197) molecules. The MenC-TT conjugate eluted as a two-component system with (M(w)) of 1.63 x 10(6) and 395,000 g x mol(-1), suggesting that some cross-linked complexes contain up to six TT molecules. Comparison of results from MALLS/RI with those obtained using UV detection highlights the differences in size and relative composition of the various subpopulations of the MenC conjugates that can be obtained using different detection systems.Keywords
This publication has 28 references indexed in Scilit:
- Light scattering and the absolute characterization of macromoleculesPublished by Elsevier ,2001
- Characterization of High-Order Diphtheria Toxin OligomersBiochemistry, 2000
- Worldwide Haemophilus influenzae Type b Disease at the Beginning of the 21st Century: Global Analysis of the Disease Burden 25 Years after the Use of the Polysaccharide Vaccine and a Decade after the Advent of ConjugatesClinical Microbiology Reviews, 2000
- Meningococcal Serogroup C Conjugate Vaccine Is Immunogenic in Infancy and Primes for MemoryThe Journal of Infectious Diseases, 1999
- Physicochemical and immunological studies on the stability of free and microsphere-encapsulated tetanus toxoid in vitroVaccine, 1996
- Refined structure of dimeric diphtheria toxin at 2.0 Å resolutionProtein Science, 1994
- Immunogenicity of a Streptococcus pneumoniae type 4 polysaccharide-protein conjugate vaccine is decreased by admixture of high doses of free saccharideVaccine, 1992
- Dimeric form of diphtheria toxin: purification and characterizationBiochemistry, 1986
- Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.The Journal of Experimental Medicine, 1980
- Characterization of group C meningococcal polysaccharide by light‐scattering spectroscopy. III. Determination of molecular weight, radius of gyration, and translational diffusional coefficientBiopolymers, 1978